Literature DB >> 15637421

Effects of endothelin-1 on human trabecular meshwork cell contraction. an in vitro cell culture model.

Mauro Cellini1, Piera Versura, Davide Trerè, Emilio C Campos.   

Abstract

Trabecular meshwork (TM) cells are now considered to play an active role in the aqueous outflow mechanism, since they exhibit smooth muscle-like contractile properties. Endothelin-1 (ET-1), a potent vasoconstrictor peptide, has been proposed to play a role in the local regulation of aqueous outflow and intra-ocular pressure control. We propose an in vitro culture model as a method in the study of ET-1-induced human trabecular meshwork (HTM) cell contractility. Experiments were performed on semi-confluent HTM cells (primary cultures established from normotensive human donor eyes) at the 2nd passage with PBS as control, ET-1, sarafotoxin 6c (a selective endothelin B receptor agonist) and Y-27632 (a selective inhibitor of rho-associated kinase). The contractile status of the cells was evaluated by a morphometric analysis of the cell area, assuming that HTM cells in culture are able to reduce their area as a consequence of cytoskeletal contraction rather than regulatory volume decrease. Our data indicate that image analysis of the HTM cell area can be a reliable method in the study of TM cell contractility, since it utilizes human cells and offers versatile opportunities for the pharmacological evaluation of drugs controlling HTM cell status. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15637421     DOI: 10.1159/000083021

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

Review 1.  Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.

Authors:  Ponugoti Vasantha Rao; Padmanabhan P Pattabiraman; Casey Kopczynski
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

2.  Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2.

Authors:  Breedge Callaghan; Karen Lester; Brian Lane; Xiaochen Fan; Katarzyna Goljanek-Whysall; David A Simpson; Carl Sheridan; Colin E Willoughby
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Inhibition of RhoA signaling with increased Bves in trabecular meshwork cells.

Authors:  Patricia K Russ; Asher I Kupperman; Sai-Han Presley; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

4.  Influence of Endothelin-1 in Aqueous Humor on Intermediate-Term Trabeculectomy Outcomes.

Authors:  Lars Choritz; Benjamin Mahmoodi; Hagen Thieme
Journal:  J Ophthalmol       Date:  2016-01-21       Impact factor: 1.909

Review 5.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  AQP1 suppression by ATF4 triggers trabecular meshwork tissue remodelling in ET-1-induced POAG.

Authors:  Yingying Zhao; Huazhang Zhu; Yangfan Yang; Yiming Ye; Youli Yao; Xiaoyan Huang; Yixiang Zhang; Xingsheng Shu; Xianxiong Chen; Yatao Yang; Junxian Ma; Le Cheng; Xiaomei Wang; Ying Ying
Journal:  J Cell Mol Med       Date:  2020-02-13       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.